CWRU engineer to grow replacement tissue for torn rotator cuffs

After 35 days, mesenchymal stem cells seeded on woven collagen biotextile have differentiated into tendon cells and populated the scaffold. Cell are elongated and run the same direction as the collagen fibers, as indicated by the green fluorescent actin fibers of cells. The differentiation is attained without growth factors, solely by the topographical cues provided by the biotextile. Credit: Mousa Younesi

A Case Western Reserve University engineer has won a $1.7 million National Institutes of Health (NIH) grant to grow replacement rotator cuffs and other large tendon groups to help heal injured soldiers and athletes, accident victims and an aging population that wants to remain active.

Ozan Akkus, professor of mechanical and aerospace engineering, has already devised a technique to reconstitute collagen—a building block of tendons—into tough fibers and induce adult to grow into tendons on those fibers.

"This is a concept that works on a lab bench," Akkus said. "We will refine the concept and test the validity on an animal model."

"Following completion of that, we may be in position for clinical applications," he continued.

Tendons are the sinew that tie muscle to bone, enabling us to push and pull, run and jump or, in the case of the rotator cuff, throw a ball or a mundane task such as reaching up to a shelf. But the cuff is susceptible to wear and damage.

The American Academy of Orthopedic Surgeons reports that nearly 200,000 Americans require shoulder surgery to repair damaged rotator cuffs annually. The failure rate for repairs exceeds 20 percent, with the rate being highest for the largest tears.

A better fix

"A simple detachment, doctors suture back in place," Akkus said. "But if the body or bulk of the tendon is damaged and there is not enough tendon to reattach, we need to regenerate bulk volume of the tendon."

To achieve that, the NIH grant will allow Akkus and a team of doctors and researchers to conduct basic science and translational work during the next five years.

At the heart of tendons is collagen, which is in skin, teeth, bones and ligaments of many species and is therefore accepted by the immune system. But, "normally, when you reconstitute collagen, it's as strong as Jell-O," Akkus said. "For a tendon, that's not an option."

His lab uses electrical currents to align collagen threads, mimicking the natural tendon and making the threads dense and strong as a tendon. And his team can make threads in bulk, which would enable manufacturers to make spools of the material—enough to accommodate hundreds of thousands of surgeries.

Woven threads are sufficiently strong to be surgically handled and sutured in place and be fully load-bearing, Akkus said. "This would enable a patient to begin physical therapy and remobilization quickly," he said.

Growing tendon tissue

The threads alone could be used as sutures to repair simple tears. But when more tendon material is needed, adult placed on the aligned collagen differentiate toward tendon cells without highly regulated growth factors, which also carry undesirable side effects or other chemicals.

Akkus' lab will investigate why differentiation occurs and whether other factors, such as mechanical stress, may further induce the stem cells to develop into tendon.

They will also test whether mesenchymal stem cells in bone marrow could complete a repair. They will drill holes in bone, tie collagen scaffolds through the holes and try to coax stem cells to spread over the scaffold and grow.

If this fails, they will seed cells on a scaffold in a petri dish and allow them to grow for a few weeks before implanting the biomaterial.

The researchers believe the technology will be useful for more than tendons. For example, mesh sheets woven with controlled pore size and geometry could be used to repair hernias or urinary incontinence. Sheets of collagen could be cast in molds of an ear or nose, for replacements for patients who suffered trauma or devastating tumors.

In his tendon project, Akkus is working with graduate research assistants Mousa Younesi and Anowarul Islam. He is collaborating with James M. Anderson, professor of pathology at Case Western Reserve School of Medicine and assistant professor Robert Gillespie, orthopedic surgeon at University Hospitals Case Medical Center. Denitsa Docheva, the leader of the "TENDON" Research Group, Department of Surgery, Ludwig-Maximilians-University, Munich, Germany is consulted on the biology of stem cells and tendon cells. Three more faculty on staff at University Hospitals Case Medical Center are involved in other applications of the technology developed in Akkus' Lab: associate professor Adonis Hijaz, urologist; and assistant professors Chad Zender and Rod Rezaee, otolaryngologists.

add to favorites email to friend print save as pdf

Related Stories

Research aims to improve repair of rotator cuff injuries

Mar 10, 2014

Rotator cuff tears are among the most common orthopedic injuries suffered by adults in the United States, due to wear and tear or the effects of age. With a 94 percent failure rate for surgical repairs of ...

Stem cells could heal equine tendon injuries

Nov 01, 2012

Tendon injuries affect athletic horses at all levels. Researchers from the University of Connecticut are studying the use of stem cells in treating equine tendon injuries. Their findings were published Oct. 16 in the Journal of ...

Recommended for you

Biologists reprogram skin cells to mimic rare disease

2 hours ago

Johns Hopkins stem cell biologists have found a way to reprogram a patient's skin cells into cells that mimic and display many biological features of a rare genetic disorder called familial dysautonomia. ...

Student seeks to improve pneumonia vaccines

Aug 20, 2014

Almost a million Americans fall ill with pneumonia each year. Nearly half of these cases require hospitalization, and 5-7 percent are fatal. Current vaccines provide protection against some strains of the ...

Seabed solution for cold sores

Aug 20, 2014

The blue blood of abalone, a seabed delicacy could be used to combat common cold sores and related herpes virus following breakthrough research at the University of Sydney.

User comments